(Q37855934)

24 August 2017

Capsaicin 8% topical patch (Qutenza)--a review of the evidence (English)

1 reference

24 August 2017

Virginia M Jones

1

1 reference

PubMed ID

21426216

24 August 2017

Katrina A Moore

series ordinal

2

1 reference

PubMed ID

21426216

24 August 2017

David M Peterson

series ordinal

3

1 reference

24 August 2017

1 January 2011

1 reference

Journal of Pain and Palliative Care Pharmacotherapy

24 August 2017

1 reference

24 August 2017

25

1 reference

24 August 2017

1

1 reference

24 August 2017

32-41

1 reference

Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy

24 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

Analgesic therapy in postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

Metabolism of capsaicinoids by P450 enzymes: a review of recent findings on reaction mechanisms, bio-activation, and detoxification processes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2010.547561

10.3109/15360288.2010.547561

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21426216